Clinical Trial Update: A Study on the Safety, Tolerability and Immune Response of Meningococcal Combined ABCWY Vaccine in Healthy Infants [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the safety, tolerability, and immune response of the Meningococcal Combined ABCWY Vaccine in healthy infants has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meningococcal Disease

Drugs mentioned

• Meningococcal Combined ABCWY Vaccine

Snippet

Sponsor: GlaxoSmithKline | Conditions: Infections, Meningococcal | Phase 2 | Status: COMPLETED